Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319964327> ?p ?o ?g. }
- W4319964327 endingPage "511" @default.
- W4319964327 startingPage "511" @default.
- W4319964327 abstract "New-generation mRNA and adenovirus vectored vaccines against SARS-CoV-2 spike protein are endowed with immunogenic, inflammatory and immunomodulatory properties. Recently, BioNTech developed a noninflammatory tolerogenic mRNA vaccine (MOGm1Ψ) that induces in mice robust expansion of antigen-specific regulatory T (Treg) cells. The Pfizer/BioNTech BNT162b2 mRNA vaccine against SARS-CoV-2 is identical to MOGm1Ψ except for the lipid carrier, which differs for containing lipid nanoparticles rather than lipoplex. Here we report that vaccination with BNT162b2 led to an increase in the frequency and absolute count of CD4posCD25highCD127low putative Treg cells; in sharp contrast, vaccination with the adenovirus-vectored ChAdOx1 nCoV-19 vaccine led to a significant decrease of CD4posCD25high cells. This pilot study is very preliminary, suffers from important limitations and, frustratingly, very hardly can be refined in Italy because of the >90% vaccination coverage. Thus, the provocative perspective that BNT162b2 and MOGm1Ψ may share the capacity to promote expansion of Treg cells deserves confirmatory studies in other settings." @default.
- W4319964327 created "2023-02-11" @default.
- W4319964327 creator A5003385222 @default.
- W4319964327 creator A5009005180 @default.
- W4319964327 creator A5013897699 @default.
- W4319964327 creator A5027998923 @default.
- W4319964327 creator A5032466668 @default.
- W4319964327 creator A5047687063 @default.
- W4319964327 creator A5050638577 @default.
- W4319964327 creator A5054791712 @default.
- W4319964327 creator A5056673453 @default.
- W4319964327 creator A5060706458 @default.
- W4319964327 creator A5074951820 @default.
- W4319964327 creator A5083637033 @default.
- W4319964327 creator A5085916135 @default.
- W4319964327 creator A5090963219 @default.
- W4319964327 date "2023-02-10" @default.
- W4319964327 modified "2023-10-14" @default.
- W4319964327 title "Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study" @default.
- W4319964327 cites W1487631743 @default.
- W4319964327 cites W1518082296 @default.
- W4319964327 cites W1989468646 @default.
- W4319964327 cites W1996123836 @default.
- W4319964327 cites W2039217616 @default.
- W4319964327 cites W2061462324 @default.
- W4319964327 cites W2067104388 @default.
- W4319964327 cites W2076359982 @default.
- W4319964327 cites W2085106134 @default.
- W4319964327 cites W2156964052 @default.
- W4319964327 cites W2163053975 @default.
- W4319964327 cites W2165198071 @default.
- W4319964327 cites W2291366206 @default.
- W4319964327 cites W2412158473 @default.
- W4319964327 cites W2615736405 @default.
- W4319964327 cites W2727145555 @default.
- W4319964327 cites W2782708334 @default.
- W4319964327 cites W3042601126 @default.
- W4319964327 cites W3120567430 @default.
- W4319964327 cites W3133745688 @default.
- W4319964327 cites W3139530191 @default.
- W4319964327 cites W3142534304 @default.
- W4319964327 cites W3148644681 @default.
- W4319964327 cites W3163785571 @default.
- W4319964327 cites W3186217635 @default.
- W4319964327 cites W3187298692 @default.
- W4319964327 cites W3189762432 @default.
- W4319964327 cites W3189962012 @default.
- W4319964327 cites W3202078153 @default.
- W4319964327 cites W3204075825 @default.
- W4319964327 cites W3206651374 @default.
- W4319964327 cites W3207886513 @default.
- W4319964327 cites W3208106660 @default.
- W4319964327 cites W3209735640 @default.
- W4319964327 cites W3215063617 @default.
- W4319964327 cites W3217355073 @default.
- W4319964327 cites W4200133104 @default.
- W4319964327 cites W4200605725 @default.
- W4319964327 cites W4207003944 @default.
- W4319964327 cites W4210450230 @default.
- W4319964327 cites W4210792795 @default.
- W4319964327 cites W4220967221 @default.
- W4319964327 cites W4220978613 @default.
- W4319964327 cites W4221104623 @default.
- W4319964327 cites W4225854071 @default.
- W4319964327 cites W4226208081 @default.
- W4319964327 cites W4226246286 @default.
- W4319964327 cites W4226478841 @default.
- W4319964327 doi "https://doi.org/10.3390/biomedicines11020511" @default.
- W4319964327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36831046" @default.
- W4319964327 hasPublicationYear "2023" @default.
- W4319964327 type Work @default.
- W4319964327 citedByCount "1" @default.
- W4319964327 countsByYear W43199643272023 @default.
- W4319964327 crossrefType "journal-article" @default.
- W4319964327 hasAuthorship W4319964327A5003385222 @default.
- W4319964327 hasAuthorship W4319964327A5009005180 @default.
- W4319964327 hasAuthorship W4319964327A5013897699 @default.
- W4319964327 hasAuthorship W4319964327A5027998923 @default.
- W4319964327 hasAuthorship W4319964327A5032466668 @default.
- W4319964327 hasAuthorship W4319964327A5047687063 @default.
- W4319964327 hasAuthorship W4319964327A5050638577 @default.
- W4319964327 hasAuthorship W4319964327A5054791712 @default.
- W4319964327 hasAuthorship W4319964327A5056673453 @default.
- W4319964327 hasAuthorship W4319964327A5060706458 @default.
- W4319964327 hasAuthorship W4319964327A5074951820 @default.
- W4319964327 hasAuthorship W4319964327A5083637033 @default.
- W4319964327 hasAuthorship W4319964327A5085916135 @default.
- W4319964327 hasAuthorship W4319964327A5090963219 @default.
- W4319964327 hasBestOaLocation W43199643271 @default.
- W4319964327 hasConcept C104317684 @default.
- W4319964327 hasConcept C105580179 @default.
- W4319964327 hasConcept C142724271 @default.
- W4319964327 hasConcept C147483822 @default.
- W4319964327 hasConcept C159047783 @default.
- W4319964327 hasConcept C203014093 @default.
- W4319964327 hasConcept C22070199 @default.
- W4319964327 hasConcept C2779134260 @default.
- W4319964327 hasConcept C3007834351 @default.